newsfilter
← Latest News
GlobeNewswire·

Immutep Receives A$4.6 million R&D Tax Incentive from French Government

Media Release SYDNEY, AUSTRALIA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Immutep Limited ((ASX: IMM, NASDAQ:IMMP) ("Immutep" or "the Company"), a late-stage immunotherapy company targeting cancer and autoimmune